Emergency management of inherited metabolic diseases

被引:69
作者
Prietsch, V
Lindner, M
Zschocke, J
Nyhan, WL
Hoffmann, GF
机构
[1] Heidelberg Univ, Kinderklin, Inst Human Genet, D-69120 Heidelberg, Germany
[2] Univ Childrens Hosp Heidelberg, Div Metab & Endocrine Dis, Heidelberg, Germany
[3] Univ San Diego, Dept Pediat, San Diego, CA 92110 USA
关键词
D O I
10.1023/A:1022040422590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inherited metabolic diseases with acute severe manifestations can be divided into five categories: (1) disorders of the intoxication type, (2) disorders with reduced fasting tolerance, (3) disorders with disturbed energy metabolism, (4) disorders of neurotransmission and (5) disorders in which no specific emergency treatment is available. Diagnostic emergency laboratory evaluation should cover all differential diagnoses that are therapeutically relevant and should always include ammonia, glucose, lactate and acid-base status as well as testing the urine for ketones. These are indispensable for planning and conducting the first steps of metabolic emergency treatment and should be available within 30 min. According to the clinical situation and biochemical derangement, special metabolic investigations must be initiated in parallel. These include acylcarnitine profiling with tandem mass spectrometry (in plasma or dried blood spots) and analysis of amino acids in plasma and of organic acids in urine. The results of all laboratory investigations relevant to the diagnosis of metabolic disorders for which specific emergency therapy exists should be available within 24 h. There is general agreement with regard to some therapeutic strategies that are clearly explained by pathophysiology: in disorders with endogenous intoxication, anabolism must be promoted and specific detoxification measures initiated. In disorders with reduced fasting tolerance, administration of glucose at the rate of hepatic glucose production forms the basis of treatment. Correction of acidosis is a major goal in disorders with disturbed mitochondrial energy metabolism, while glucose supply may have to be limited. Many current therapeutic strategies are based on case reports and personal experiences at different metabolic centres. The aim of devising the 'best' management is often hampered by the lack of objective evidence of efficacy.
引用
收藏
页码:531 / 546
页数:16
相关论文
共 43 条
[1]   BRANCHED-CHAIN AMINO-ACID FREE PARENTERAL-NUTRITION IN THE TREATMENT OF ACUTE METABOLIC DECOMPENSATION IN PATIENTS WITH MAPLE SYRUP URINE DISEASE [J].
BERRY, GT ;
HEIDENREICH, R ;
KAPLAN, P ;
LEVINE, F ;
MAZUR, A ;
PALMIERI, MJ ;
YUDKOFF, M ;
SEGAL, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (03) :175-179
[2]   POSTOPERATIVE METABOLIC DECOMPENSATION IN MAPLE-SYRUP-URINE-DISEASE IS COMPLETELY PREVENTED BY INSULIN [J].
BIGGEMANN, B ;
ZASS, R ;
WENDEL, U .
JOURNAL OF INHERITED METABOLIC DISEASE, 1993, 16 (05) :912-913
[3]   Assessment of energy expenditure in metabolic disorders [J].
Bodamer, OAF ;
Hoffmann, GF ;
Visser, GH ;
Janecke, A ;
Linderkamp, O ;
Leonard, JV ;
Fasoli, L ;
Rating, D .
EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (Suppl 1) :S24-S28
[4]   Very long chain acyl-CoA dehydrogenase deficiency: Successful treatment of acute cardiomyopathy [J].
BrownHarrison, MC ;
Nada, MA ;
Sprecher, H ;
VianeySaban, C ;
Farquhar, J ;
Gilladoga, AC ;
Roe, CR .
BIOCHEMICAL AND MOLECULAR MEDICINE, 1996, 58 (01) :59-65
[5]   URINARY-EXCRETION OF L-CARNITINE AND ACYLCARNITINES BY PATIENTS WITH DISORDERS OF ORGANIC-ACID METABOLISM - EVIDENCE FOR SECONDARY INSUFFICIENCY OF L-CARNITINE [J].
CHALMERS, RA ;
ROE, CR ;
STACEY, TE ;
HOPPEL, CL .
PEDIATRIC RESEARCH, 1984, 18 (12) :1325-1328
[6]   INTERCURRENT ILLNESS IN INBORN-ERRORS OF INTERMEDIARY METABOLISM [J].
DIXON, MA ;
LEONARD, JV .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (11) :1387-1391
[7]   CONTINUOUS VENOVENOUS HEMOFILTRATION IN THE ACUTE TREATMENT OF INBORN-ERRORS OF METABOLISM [J].
FALK, MC ;
KNIGHT, JF ;
ROY, LP ;
WILCKEN, B ;
SCHELL, DN ;
OCONNELL, AJ ;
GILLIS, J .
PEDIATRIC NEPHROLOGY, 1994, 8 (03) :330-333
[8]   Alternative pathway therapy for urea cycle disorders [J].
Feillet, F ;
Leonard, JV .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 :101-111
[9]   Resting energy expenditure in disorders of propionate metabolism [J].
Feillet, F ;
Bodamer, OAF ;
Dixon, MA ;
Sequeira, S ;
Leonard, JV .
JOURNAL OF PEDIATRICS, 2000, 136 (05) :659-663
[10]  
Fernandes J., 2000, Inborn Metabolic Diseases: Diagnosis and Treatment